Solutions to Enable Regional Genomic Medicine eConsult Services (R43/R44 Clinical Trial Optional)

Active
Yes
Status
Posted
Published Date
January 9th, 2024
Close Date
May 30th, 2024
Opportunity No.
PAR-24-106

Agency

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Small Businesses

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Summary

The National Institutes of Health is offering a grant opportunity titled "Solutions to Enable Regional Genomic Medicine eConsult Services (R43/R44 Clinical Trial Optional)". This grant aims to support small businesses in developing solutions for commercialization that enable regional genomic medicine eConsult services. The grant does not require cost sharing or matching. The funding instrument type is a grant, and the category of funding activity is health. The eligible applicants for this grant are small businesses. Non-domestic entities and non-U.S. components of U.S. organizations are not eligible to apply. The grant provides additional information on eligibility criteria. The close date for applications is May 30, 2024. For more information and to apply, please visit the following website: link. For any inquiries, please contact NIH Grants Information at grantsinfo@nih.gov.

Description

The purpose of this notice of funding opportunity (NOFO) is to support applications from small businesses to develop solutions for commercialization that enable regional genomic medicine eConsult Service.

Contact Information

Attachments
0 KB

Opportunity Lifecycle

Title
Type
Grant

Similar Opportunities

Solutions to Enable Regional Genomic Medicine eConsult Services (R41/R42 Clinical Trial Optional)
National Institutes of Health
The National Institutes of Health is offering a grant opportunity titled "Solutions to Enable Regional Genomic Medicine eConsult Services (R41/R42 Clinical Trial Optional)". This grant aims to support small businesses in developing solutions for commercialization that enable regional genomic medicine eConsult services. The grant does not require cost sharing or matching. The funding instrument type is a grant, and the category of funding activity is health. The eligible applicants for this grant are small businesses. Non-domestic entities and non-U.S. components of U.S. organizations are not eligible to apply. The grant provides additional information on eligibility criteria. The close date for applications is May 30, 2024. For more information and to apply, visit the following link: [Additional Information](http://grants.nih.gov/grants/guide/pa-files/PAR-24-107.html). For any inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
Research on the Impact of and Methods for Implementing Regional Genomic Medicine eConsult Services (U01 Clinical Trials Optional)
National Institutes of Health
The National Institutes of Health (NIH) has posted a grant opportunity titled "Research on the Impact of and Methods for Implementing Regional Genomic Medicine eConsult Services (U01 Clinical Trials Optional)". This grant aims to fund research on the impact and methods of implementing regional clinician-to-clinician genomic medicine eConsult services. The funded sites will focus on designing, developing, and implementing regional genomic medicine eConsult services, as well as providing outreach to potential users, including those in underserved settings. The research will also assess the impact on key stakeholders and develop successful implementation strategies and resources that can be widely shared and adopted. The grant does not require cost sharing or matching. The deadline for applications is May 30, 2024. For more information and to apply, visit the following link: [http://grants.nih.gov/grants/guide/rfa-files/RFA-HG-24-001.html](http://grants.nih.gov/grants/guide/rfa-files/RFA-HG-24-001.html).
Advancing Genomic Medicine Research (R03 Clinical Trial Not Allowed)
National Institutes of Health
The National Institutes of Health (NIH) is offering a grant opportunity titled "Advancing Genomic Medicine Research (R03 Clinical Trial Not Allowed)". This grant aims to stimulate innovation and advance understanding of the use and sharing of genomic information and technologies in clinical care for all individuals, regardless of their racial/ethnic background or socioeconomic status. The R03 grant mechanism supports small research projects that can be completed in a short period of time with limited resources. Examples of eligible projects include pilot or feasibility studies, secondary analysis of existing data, small self-contained research projects, or the development of research methodology. Applicants are not required to provide extensive background material or preliminary information in their grant application. Instead, reviewers will focus on the conceptual framework, level of innovation, and potential to significantly advance knowledge or understanding in the field. Justification for the proposed work can be supported through literature citations, data from other sources, or investigator-generated data if available. Preliminary data are not mandatory but can be included if applicable. The grant has a funding ceiling of $500,000 and does not require cost sharing or matching. The opportunity falls under the category of Health and is classified as discretionary. The closing date for applications is February 11, 2025, and the archive date is March 19, 2025. Eligible applicants include Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), eligible agencies of the Federal Government, faith-based or community-based organizations, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Indian/Native American Tribal Governments (Other than Federally Recognized), regional organizations, Tribally Controlled Colleges and Universities (TCCUs), U.S. Territories or Possessions. Non-domestic (non-U.S.) entities and non-domestic components of U.S. organizations are not eligible to apply. However, foreign components, as defined in the NIH Grants Policy Statement, are allowed. For more information and to apply, please visit the following link: [Advancing Genomic Medicine Research Grant](http://grants.nih.gov/grants/guide/rfa-files/RFA-HG-23-048.html). If you have any inquiries, you can contact NIH Grants Information at grantsinfo@nih.gov.
Advancing Genomic Medicine Research (R21 Clinical Trial Optional)
National Institutes of Health
The National Institutes of Health (NIH) is offering a grant opportunity titled "Advancing Genomic Medicine Research (R21 Clinical Trial Optional)". This grant aims to stimulate innovation and advance understanding of the use and sharing of genomic information and technologies in clinical care. The grant is open to various eligible applicants, including Alaska Native and Native Hawaiian Serving Institutions, Faith-based or Community-based Organizations, and U.S. Territories or Possessions. The funding instrument for this opportunity is a grant, and there is no cost sharing or matching requirement. The maximum award ceiling is $250,000. The deadline for applications is February 11, 2025. For more information and to apply, visit the following link: [Advancing Genomic Medicine Research Grant](http://grants.nih.gov/grants/guide/rfa-files/RFA-HG-23-033.html).